Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

U.S. Leadership

Content :

U.S. Leadership

Angela Bechan

Head of North America Communications


As Head of North America Communications, Angela Bechan is responsible for building and overseeing external and internal communication strategies and activities for the North America region, including messaging, media outreach, digital strategy, product communications and internal communications. Having worked in the communications field for more than 20 years, Angela brings to the role extensive experience, both in the U.S. and internationally, to enhance the image and reputation of Sanofi in North America and drive communications excellence in our ever-changing healthcare environment. In addition to her North America responsibility, Angela also serves on Sanofi’s Global Communications Leadership Team.

Prior to joining Sanofi, Angela worked at Takeda Pharmaceuticals International, Inc. for 13 years, where she was most recently Vice President of Corporate Communications responsible for all corporate communications for the company’s four international commercial regions and global manufacturing, including the United States, Emerging Markets, Europe and Canada, and North Asia. Angela demonstrated her leadership experience in a variety of cultural contexts most notably spending significant time working in Takeda’s Japanese headquarters in Tokyo and living and working in Switzerland. Prior to Takeda, Angela held positions of increasing responsibility at Edelman Public Relations Worldwide and Andersen Consulting (Accenture).

Angela holds a Bachelor of Science degree from the E.W. Scripps School of Journalism at Ohio University.

Adam Gluck

Head of US Government Relations


In his role as Head of US Government Relations, Adam Gluck leads the Sanofi US government relations operations and establishes the federal and state legislative and executive branch priorities pursued by the US government relations units for all Sanofi operations in the US.

Adam joined Sanofi from Biogen, where he was most recently the Vice President of US Government Affairs & Patient Advocacy. In this role, Adam led the US federal, state, policy, and patient advocacy teams. During his nine years at Biogen, Adam served as the company’s lead federal lobbyist and was responsible for designing and building their European Public Policy & Government Affairs organization.

Prior to joining Biogen, Adam was a Senior Managing Director at Sonnenschein Nath & Rosenthal LLP (now Dentons LLP), where he led the Public Law and Policy Strategies public health practice team. At Sonnenschein, Adam represented a diverse range of patient advocacy organizations and corporations before the US Congress and Executive branch. His career also includes close to ten years on Capitol Hill working for four Congressional Members, including working as senior health policy advisor to Senator Tom Harkin (D-IA) and legislative director for Congressman Gene Green (D-TX). Adam was also the Senior House Legislative Liaison for the Children’s Defense Fund.

Adam holds a Bachelor of Arts degree in Political Science from the University of Michigan.

Chad Hoover

Chief Commercial Officer, Sanofi Pasteur North America and General Manager, Sanofi Pasteur US


As Chief Commercial Officer, Sanofi Pasteur North America and General Manager, Sanofi Pasteur US, Chad Hoover directs the development and implementation of commercial strategies across U.S. and Canadian Commercial Operations to ensure sustainable growth and build on Sanofi Pasteur’s leadership position in the vaccines market.

Responsible for more than $3 billion in North American vaccine sales, Chad concentrates on guiding the specialized activities of each area under his leadership, including Sanofi Pasteur’s subsidiary business, VaxServe.

Chad has taken on roles of increasing responsibility during his 23 years with Sanofi Pasteur. Most recently, he served as Vice President and Chief Commercial Officer for the U.S.

Chad also demonstrates his commitment to vaccines through his co-leadership role with the Biotechnology Industry Organization’s (BIO) Vaccine Policy Advisory Committee.

He is a graduate of Montana State University, where he earned a bachelor of science degree.

Ching Jaw

US Diabetes & Cardiovascular Finance Business Partner and North America Chief Financial Officer


In his role as US Diabetes & Cardiovascular Finance Business Partner and North America Chief Financial Officer (CFO), Ching Jaw is the Finance business partner to Christopher Kaplan and his leadership team. In addition to his role as the North America CFO Ching is the Chair of the North America Regional Finance Council and is responsible for the overall integrity of the North America Financial close and reporting process and talent management in the Finance function across the Region.

Ching joined Sanofi from Roche Holding Ltd., where he was most recently Chief Financial Officer for Ventana Medical Systems, a member of the Roche Group. With Genentech since 2001, and then Roche, following their acquisition of Genentech, Ching has held a wide variety of finance positions over the years, including two years as Chief Financial Officer of Roche in Taiwan and as Head of R&D Finance. Prior to joining Genentech, Ching worked at Honeywell and Caterpillar Inc.

A former Army Platoon Commander and Liaison Officer in the Taiwanese Army, Ching holds a Bachelor of Science degree in Naval Architecture from National Taiwan University, a Master of Science in Aerospace Engineering from the University of Michigan, and an M.B.A. in Finance and General Management from the University of Chicago Graduate School of Business.

Christopher Kaplan

North America Head, Diabetes & Cardiovascular Business Unit; Chair, U.S. Country Council


Christopher Kaplan is North America Head of the Diabetes & Cardiovascular Business Unit. In this role, he oversees all Diabetes and Cardiovascular business operations, including Sales, Marketing, Market Access and Integrated Care, across the U.S. and Canada with responsibility for key brands including Toujeo®, Lantus® and Praluent®.

Christopher serves as a member of Sanofi’s Global Senior Leadership Team, the Global Diabetes & Cardiovascular Leadership Team, and is Chair of the Sanofi U.S. Country Council. Christopher is also a Board Member for the National Pharmaceutical Council.

He joined Sanofi in January 2016 as Global Diabetes Franchise Head. Previously, Christopher held multiple executive leadership roles in several highly respected healthcare companies. He began his pharmaceutical career as a sales representative with Bristol Myers Squibb and progressed to roles in Sales and Marketing across the U.S., France and Italy.

During his 12 year tenure at Novartis, Christopher acted as the Global Head of the Cardiovascular & Metabolic Franchise, as well as in country and regional GM roles, demonstrating his leadership abilities in a variety of cultural contexts including Sweden and Switzerland. Upon returning to the U.S., he served as President of the Cardiovascular and Metabolic Operating Unit, and then concluded his time at Novartis as President & GM of the East Operating Unit. Prior to Novartis, Christopher was Senior Vice President and Chief Marketing Officer for Boehringer Ingelheim.

Christopher received his Bachelor of Arts from Columbia University and Masters of Science Degree from the University of Pennsylvania.

Chan Lee

North America General Counsel


Chan Lee is North America General Counsel and a member of the Legal Steering Committee. Chan has more than twenty years of legal experience both in law firms and in-house. He has extensive knowledge of the pharmaceutical industry and was most recently at Pfizer as Senior Vice President and Chief Counsel for Pfizer’s Global Innovative Health. He has worked in a number of practice areas, including transactions, regulatory law, market access, product support and international support.

Chan leads the North America Legal Team, which includes Litigation and Government Investigations, Product Support and Regulatory Law, Market Access Legal, Employment Law, Legal Operations and the Canadian Legal Team. North America Legal Team provides proactive, solutions-oriented legal counseling and engages in thoughtful risk taking to help achieve business objectives.

Chan has a Juris Doctor degree from the University of California at Berkeley (Boalt Hall) and has a Bachelor of Science degree in Applied Economics from Cornell University. After graduating from law school, Chan served as a law clerk to William T. Allen of the Delaware Chancery Court.

Robert Long

Head of Consumer Health Care North America (Chattem, Inc.)


Robert Long is Head of Consumer Health Care North America (Chattem, Inc.).

Prior to this role, Robert served in various executive positions in the US CHC (Chattem) business. Before joining Chattem, he was Chief Financial Officer for a Chattanooga-based hosiery manufacturer and served as a Senior Audit Manager with Ernst & Young, LLP, and Arthur Andersen, covering principally the Southeastern U.S.

Robert is a CPA and a member of the Tennessee Society of CPAs and American Institute of CPAs.

He earned his Bachelor of Science in Finance, with a Minor in Economics, from the University of Tennessee (Chattanooga).

Yann Mazabraud

US General Manager & NA Region Head for Rare Diseases, Sanofi Genzyme


Yann Mazabraud is the US General Manager and the North America Region Head for Rare Diseases for Sanofi Genzyme. In this role, he is responsible for the leadership, strategy and overall success of this business.

Yann joined Genzyme in 1999, and over the past 17 years, he has held roles of increasing responsibility within the company. He was hired as a Clinical Science Associate in France and spent 12 years with the French affiliate, where he held sales and marketing leadership roles in Rare Diseases, and served as the Business Unit Director for the Renal-Cardiovascular business.

In 2011, Yann joined Genzyme in Latin America as the Head of Rare Diseases and was promoted to Vice President, Head of Genzyme in Latin America in May 2014.

Prior to joining Genzyme, Yann worked in a consumer goods business in Germany and in a medical devices business in France.

Yann holds a master’s degree in business administration from the Ecole Superieure de Commerce de la Rochelle in France.

Eric Racine, Pharm. D, MBA

Vice President & Head, North America Public Affairs


Dr. Racine is Head of North America Public Affairs at Sanofi. Eric leads the US and Canada team of public affairs and advocacy professionals that engage external stakeholders on healthcare policy and patient access to medicines and vaccines. He sits on the Sanofi US Country Council, the Sanofi US Commercial Committee, and the Sanofi Global Public Affairs Leadership Team.

Eric has held different roles and led teams throughout his career enabling innovative forms of collaboration across multiple external stakeholders where the needs of patients were at the center of these efforts. He joined Sanofi in 2002 as Senior Director for Pharmacy Affairs and he has subsequently held progressive leadership positions in U.S. and global roles, spanning medical marketing, market access, healthcare policy, public affairs and patient advocacy. He led the company’s efforts in Patient Advocacy, building a network of Patient Advocacy Officers across the company to engage in continuous dialogue with the patient advocacy community. Prior to entering the pharmaceutical industry, Eric held various positions in clinical pharmacy in the US and Canada including academic, patient care and management roles.

Dr. Racine holds an Executive MBA from Rutgers University in New Jersey, a Doctor of Pharmacy from Wayne State University in Michigan, and a Bachelor of Science in Pharmacy from Laval University in Quebec, Canada. Eric also leads the Public Affairs & Advocacy Sanofi Fellowship program with Rutgers University Ernest Mario School of Pharmacy.

Holly Schachner, MD

Medical Affairs Head for North America, Diabetes/Cardiovascular (DCV) Business Unit and US Medical Chair, Sanofi


Holly Schachner, MD is the Medical Affairs Head for North America, DCV Business Unit and the US Medical Chair at Sanofi. She has responsibilities to lead the medical teams across the Diabetes and Cardiovascular unit in North America, as well as responsibility for alignment across the US medical groups in the different Sanofi business units. Prior to joining Sanofi, Holly led Global Medical Affairs at Bayer Diabetes Care to bring innovative technology to people and their healthcare providers to manage diabetes. She has also worked at Pfizer in Cardio-metabolic diseases. Holly’s past academic research includes NIH research in diabetes in children and adolescents.

Holly received her undergraduate training at the University of Michigan in Ann Arbor and her medical degree at the State University of New York at Stony Brook. She completed her Pediatric residency and Pediatric Endocrinology fellowship at the Mount Sinai Hospital in New York. Following her fellowship, she was an Assistant Clinical Professor of Pediatrics at Columbia University.

Clint Wallace

Head of Human Resources, North America


In his role as Head of Human Resources (HR), North America, Clint Wallace is responsible for providing strategic HR leadership to Sanofi’s North America HR organization. He partners closely with the executive team to drive the organizational climate necessary in growing an innovative and collaborative company. In addition to his North America responsibility, Clint also serves on the Global HR Leadership team.

Prior to joining Sanofi, Clint was with BASF Corporation, where he was Vice President of Human Resources for North America, providing strategic HR leadership to BASF’s North America HR organization including: organization design, talent resourcing, career planning, reward and performance management tools and talent succession planning. Prior to BASF, Clint held numerous positions within GE Healthcare and Pratt & Whitney.

Clint also served as a Commissioned Officer in the US Air Force Reserve and, after 21 years of service, retired in June 2008.

Clint holds a Master of Science degree in Business Administration from Rensselaer Polytechnic Institute and a Bachelor of Science degree in Manufacturing Engineering from Central Connecticut State University.

Last update: March 22, 2017